Genomelabs India Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 07-07-2024
- Paid Up Capital ₹ 0.35 M
as on 07-07-2024
- Company Age 20 Year,
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2022)
- Profit -29.25%
(FY 2022)
- Ebitda 59.18%
(FY 2022)
- Net Worth -11.19%
(FY 2022)
- Total Assets 1.76%
(FY 2022)
About Genomelabs India
The Corporate was formerly known as Genomlabs India Private Limited. The Company is engaged in the Real Estate And Construction Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.35 M, as per Ministry of Corporate Affairs (MCA) records.
Lakshmi Dandu and Nagaraju Pathapati serve as directors at the Company.
- CIN/LLPIN
U24230TG2004PTC044946
- Company No.
044946
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Dec 2004
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Genomelabs India?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Lakshmi Dandu  | Additional Director | 21-Mar-2024 | Current |
| Nagaraju Pathapati | Director | 23-Dec-2004 | Current |
Financial Performance of Genomelabs India.
Genomelabs India Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 29.25% decrease in profit. The company's net worth observed a substantial decline by a decrease of 11.19%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Genomelabs India?
In 2021, Genomelabs India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Pnr Infra India Private LimitedActive 31 years 3 monthsLakshmi Dandu and Nagaraju Pathapati are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Genomelabs India?
Unlock and access historical data on people associated with Genomelabs India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Genomelabs India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Genomelabs India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
